1 completed, 1 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow olorinab: new trials by email Literature Review of olorinab trials Research Report on olorinab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Olorinab in Irritable Bowel Syndrome With Predominant Constipation (IBS-C) and Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D) Olorinab, Placebo - Irritable Bowel Syndrome | Phase 2 | Terminated | Arena Pharmaceuticals | 273 | 2019-07-24 | 2025-01-30 |
| Tolerability, Pharmacokinetics, and Efficacy of APD371 in Participants With Crohn's Disease Experiencing Abdominal Pain Olorinab - Crohn's Disease, Abdominal Pain | Phase 2 | Completed | Arena Pharmaceuticals | 14 | 2017-07-19 | 2021-11-02 |
Abdominal Pain (2) · Crohn Disease (1) · Irritable Bowel Syndrome (1)
United States (2)
Arena CT.gov Administrator (2)